SG/CALL/EDWARDS LIFESCIENCES/115/0.1/21.06.24

SG/CALL/EDWARDS LIFESCIENCES/115/0.1/21.06.24 Share Price

DE000SW8FQU7

Real-time Boerse Frankfurt Warrants 14:23:33 17/05/2024 BST
0.001 ^EUR	0.00%

Current month	-95.45%
1 month	-99.33%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart EDWARDS LIFESCIENCES CORPORATION

Chart SG/CALL/EDWARDS LIFESCIENCES/115/0.1/21.06.24

Latest news about EDWARDS LIFESCIENCES CORPORATION

Edwards Lifesciences : First Quarter 2024 Fact Sheet	05-15	PU
Deutsche Bank Upgrades Edwards Lifesciences to Buy From Hold, Raises Price Target to $103 From $86	05-14	MT
Edwards Lifesciences Insider Sold Shares Worth $439,038, According to a Recent SEC Filing	05-13	MT
Edwards Lifesciences Faces EU Antitrust Complaint By Meril	05-13	MT

More news

Quotes 5-day view

Date	Price	Change
17/05/24	0.001	0.00%
16/05/24	0.001	-75.00%
15/05/24	0.004	+300.00%
14/05/24	0.001	0.00%
13/05/24	0.001	-80.00%

Real-time Boerse Frankfurt Warrants

Last update May 17, 2024 at 02:23 pm

More quotes

Static data

Product type	Plain-Vanilla-Warrants
Buy / Sell	CALL
Underlying	EDWARDS LIFESCIENCES CORPORATION
Issuer	Société Générale
WKN	SW8FQU
ISIN	DE000SW8FQU7
Date issued	02/04/2024
Strike	115 $
Maturity	21/06/2024 (35 Days)
Parity	10 : 1
Emission price	0.28 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	0.24 €
Lowest since issue	0.001 €
Spread	0.019 €
Spread %	95.00%

Company Profile

Edwards Lifesciences Corporation specializes in designing, manufacturing and marketing medical systems and devices for treating cardiovascular diseases. Net sales break down by family of products as follows: - heart valves and surgery products (67.9%); - hemodynamic monitoring systems (15.5%); - other (16.6%): balloon catheters, artificial implants, etc. Net sales are distributed geographically as follows: the United States (58.4%), Europe (22.2%), Japan (7.6%) and other (11.8%).

Sector

More about the company